A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin

Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks

(2015)   Oncotarget

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma

(2015) Ken Maes et al.   Oncotarget

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy

(2015) Alboukadel Kassambara et al.   Oncotarget

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting homologous recombination-mediated DNA repair in cancer

(2014) João FS Carvalho et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts

(2014) Fei Huang et al.   PLoS One

Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity

(2013) P Vejpongsa et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma

(2012) Pierre Tennstedt et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase

(2012) Fei Huang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Suberoylanilide Hydroxamic Acid as a Radiosensitizer through Modulation of RAD51 Protein and Inhibition of Homology-Directed Repair in Multiple Myeloma

(2012) X. Chen et al.   MOLECULAR CANCER RESEARCH

Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening

(2011) Fei Huang et al.   ACS Chemical Biology

Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics

(2011) Zhengguan Yang et al.   BIOCHEMICAL PHARMACOLOGY

Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors

(2011) P. Neri et al.   BLOOD

Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma

(2011) Yong Li et al.   JOURNAL OF SURGICAL ONCOLOGY

Initial genome sequencing and analysis of multiple myeloma

(2011) Michael A. Chapman et al.   NATURE

Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair

(2011) D. T. Long et al.   SCIENCE

A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

(2010) M. Graeser et al.   CLINICAL CANCER RESEARCH

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome

(2010) Raffaela Barbano et al.   INTERNATIONAL JOURNAL OF CANCER

Overexpression of RAD51 occurs in aggressive prostatic cancer

(2009) Anita Mitra et al.   HISTOPATHOLOGY

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

(2009) Neil Johnson et al.   MOLECULAR CELL

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

(2008) M. A. Shammas et al.   BLOOD

Impaired NHEJ function in multiple myeloma

(2008) Clara Yang et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair

(2007) Damian M.S. Spencer et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS